カテゴリー： 世界, 医療/バイオ, QYResearch

プロプラノロールのグローバル市場2023年：経口、注射

【英語タイトル】Global Propranolol Market Research Report 2023

QYResearchが出版した調査資料（QYR23MA7537）・商品コード：QYR23MA7537
・発行会社（調査会社）：QYResearch
・発行日：2023年3月（※2025年版があります。お問い合わせください。）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

本調査レポートは世界のプロプラノロール市場について調査・分析し、世界のプロプラノロール市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（経口、注射）、用途別セグメント分析（不整脈、高血圧、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentivaなどが含まれています。世界のプロプラノロール市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、プロプラノロール市場規模を推定する際に考慮しました。

・プロプラノロール市場の概要
- 製品の定義
- プロプラノロールのタイプ別セグメント
- 世界のプロプラノロール市場規模：タイプ別分析（経口、注射）
- プロプラノロールの用途別セグメント
- 世界のプロプラノロール市場規模：用途別分析（不整脈、高血圧、その他）
- 世界のプロプラノロール市場規模予測（2018年-2029年）
- プロプラノロールの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- プロプラノロール市場の競争状況およびトレンド

・プロプラノロールの地域別市場規模
- 北米のプロプラノロール市場規模（2018年-2029年）
- アメリカのプロプラノロール市場規模（2018年-2029年）
- ヨーロッパのプロプラノロール市場規模（2018年-2029年）
- アジア太平洋のプロプラノロール市場規模（2018年-2029年）
- 中国のプロプラノロール市場規模（2018年-2029年）
- 日本のプロプラノロール市場規模（2018年-2029年）
- 韓国のプロプラノロール市場規模（2018年-2029年）
- インドのプロプラノロール市場規模（2018年-2029年）
- オーストラリアのプロプラノロール市場規模（2018年-2029年）
- 中南米のプロプラノロール市場規模（2018年-2029年）
- 中東・アフリカのプロプラノロール市場規模（2018年-2029年）

・タイプ別セグメント：経口、注射
- 世界のプロプラノロールのタイプ別販売量（2018年-2023年）
- 世界のプロプラノロールのタイプ別売上（2018年-2023年）
- 世界のプロプラノロールのタイプ別価格

・用途別セグメント：不整脈、高血圧、その他
- 世界のプロプラノロールの用途別販売量（2018年-2023年）
- 世界のプロプラノロールの用途別売上（2018年-2023年）
- 世界のプロプラノロールの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentiva

・産業チェーンと販売チャネルの分析
- プロプラノロール産業チェーン分析
- プロプラノロールの主要原材料
- プロプラノロールの販売チャネル
- プロプラノロールのディストリビューター
- プロプラノロールの主要顧客

・プロプラノロール市場ダイナミクス
- プロプラノロールの業界動向
- プロプラノロール市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Highlights
The global Propranolol market was valued at US$ 386 million in 2022 and is anticipated to reach US$ 477.8 million by 2029, witnessing a CAGR of 3.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.
Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Propranolol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propranolol.
The Propranolol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Propranolol market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propranolol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Segment by Type
Oral
Injection
Segment by Application
Arrhythmia
Hypertension
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Propranolol market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Propranolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Propranolol industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Propranolol Market Overview
1.1 Product Overview and Scope of Propranolol
1.2 Propranolol Segment by Type
1.2.1 Global Propranolol Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Injection
1.3 Propranolol Segment by Application
1.3.1 Global Propranolol Market Value by Application: (2023-2029)
1.3.2 Arrhythmia
1.3.3 Hypertension
1.3.4 Others
1.4 Global Propranolol Market Size Estimates and Forecasts
1.4.1 Global Propranolol Revenue 2018-2029
1.4.2 Global Propranolol Sales 2018-2029
1.4.3 Global Propranolol Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Propranolol Market Competition by Manufacturers
2.1 Global Propranolol Sales Market Share by Manufacturers (2018-2023)
2.2 Global Propranolol Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Propranolol Average Price by Manufacturers (2018-2023)
2.4 Global Propranolol Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Propranolol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Propranolol, Product Type & Application
2.7 Propranolol Market Competitive Situation and Trends
2.7.1 Propranolol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Propranolol Players Market Share by Revenue
2.7.3 Global Propranolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Propranolol Retrospective Market Scenario by Region
3.1 Global Propranolol Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Propranolol Global Propranolol Sales by Region: 2018-2029
3.2.1 Global Propranolol Sales by Region: 2018-2023
3.2.2 Global Propranolol Sales by Region: 2024-2029
3.3 Global Propranolol Global Propranolol Revenue by Region: 2018-2029
3.3.1 Global Propranolol Revenue by Region: 2018-2023
3.3.2 Global Propranolol Revenue by Region: 2024-2029
3.4 North America Propranolol Market Facts & Figures by Country
3.4.1 North America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Propranolol Sales by Country (2018-2029)
3.4.3 North America Propranolol Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Propranolol Market Facts & Figures by Country
3.5.1 Europe Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Propranolol Sales by Country (2018-2029)
3.5.3 Europe Propranolol Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Propranolol Market Facts & Figures by Country
3.6.1 Asia Pacific Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Propranolol Sales by Country (2018-2029)
3.6.3 Asia Pacific Propranolol Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Propranolol Market Facts & Figures by Country
3.7.1 Latin America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Propranolol Sales by Country (2018-2029)
3.7.3 Latin America Propranolol Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Propranolol Market Facts & Figures by Country
3.8.1 Middle East and Africa Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Propranolol Sales by Country (2018-2029)
3.8.3 Middle East and Africa Propranolol Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Propranolol Sales by Type (2018-2029)
4.1.1 Global Propranolol Sales by Type (2018-2023)
4.1.2 Global Propranolol Sales by Type (2024-2029)
4.1.3 Global Propranolol Sales Market Share by Type (2018-2029)
4.2 Global Propranolol Revenue by Type (2018-2029)
4.2.1 Global Propranolol Revenue by Type (2018-2023)
4.2.2 Global Propranolol Revenue by Type (2024-2029)
4.2.3 Global Propranolol Revenue Market Share by Type (2018-2029)
4.3 Global Propranolol Price by Type (2018-2029)
5 Segment by Application
5.1 Global Propranolol Sales by Application (2018-2029)
5.1.1 Global Propranolol Sales by Application (2018-2023)
5.1.2 Global Propranolol Sales by Application (2024-2029)
5.1.3 Global Propranolol Sales Market Share by Application (2018-2029)
5.2 Global Propranolol Revenue by Application (2018-2029)
5.2.1 Global Propranolol Revenue by Application (2018-2023)
5.2.2 Global Propranolol Revenue by Application (2024-2029)
5.2.3 Global Propranolol Revenue Market Share by Application (2018-2029)
5.3 Global Propranolol Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Apotex
6.1.1 Apotex Corporation Information
6.1.2 Apotex Description and Business Overview
6.1.3 Apotex Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Apotex Propranolol Product Portfolio
6.1.5 Apotex Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Propranolol Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Atnas Pharma
6.3.1 Atnas Pharma Corporation Information
6.3.2 Atnas Pharma Description and Business Overview
6.3.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Atnas Pharma Propranolol Product Portfolio
6.3.5 Atnas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Propranolol Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Propranolol Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Propranolol Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Propranolol Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Yabang Pharma
6.8.1 Yabang Pharma Corporation Information
6.8.2 Yabang Pharma Description and Business Overview
6.8.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yabang Pharma Propranolol Product Portfolio
6.8.5 Yabang Pharma Recent Developments/Updates
6.9 Sawai Seiyaku
6.9.1 Sawai Seiyaku Corporation Information
6.9.2 Sawai Seiyaku Description and Business Overview
6.9.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sawai Seiyaku Propranolol Product Portfolio
6.9.5 Sawai Seiyaku Recent Developments/Updates
6.10 ABZ-Pharma
6.10.1 ABZ-Pharma Corporation Information
6.10.2 ABZ-Pharma Description and Business Overview
6.10.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABZ-Pharma Propranolol Product Portfolio
6.10.5 ABZ-Pharma Recent Developments/Updates
6.11 Towa Yakuhin
6.11.1 Towa Yakuhin Corporation Information
6.11.2 Towa Yakuhin Propranolol Description and Business Overview
6.11.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Towa Yakuhin Propranolol Product Portfolio
6.11.5 Towa Yakuhin Recent Developments/Updates
6.12 Zydus Pharma
6.12.1 Zydus Pharma Corporation Information
6.12.2 Zydus Pharma Propranolol Description and Business Overview
6.12.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zydus Pharma Propranolol Product Portfolio
6.12.5 Zydus Pharma Recent Developments/Updates
6.13 Nichi-Iko Pharmaceutical
6.13.1 Nichi-Iko Pharmaceutical Corporation Information
6.13.2 Nichi-Iko Pharmaceutical Propranolol Description and Business Overview
6.13.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio
6.13.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.14 Intas Pharma
6.14.1 Intas Pharma Corporation Information
6.14.2 Intas Pharma Propranolol Description and Business Overview
6.14.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Intas Pharma Propranolol Product Portfolio
6.14.5 Intas Pharma Recent Developments/Updates
6.15 IFET
6.15.1 IFET Corporation Information
6.15.2 IFET Propranolol Description and Business Overview
6.15.3 IFET Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.15.4 IFET Propranolol Product Portfolio
6.15.5 IFET Recent Developments/Updates
6.16 Iqfarma
6.16.1 Iqfarma Corporation Information
6.16.2 Iqfarma Propranolol Description and Business Overview
6.16.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iqfarma Propranolol Product Portfolio
6.16.5 Iqfarma Recent Developments/Updates
6.17 Zentiva
6.17.1 Zentiva Corporation Information
6.17.2 Zentiva Propranolol Description and Business Overview
6.17.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zentiva Propranolol Product Portfolio
6.17.5 Zentiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Propranolol Industry Chain Analysis
7.2 Propranolol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Propranolol Production Mode & Process
7.4 Propranolol Sales and Marketing
7.4.1 Propranolol Sales Channels
7.4.2 Propranolol Distributors
7.5 Propranolol Customers
8 Propranolol Market Dynamics
8.1 Propranolol Industry Trends
8.2 Propranolol Market Drivers
8.3 Propranolol Market Challenges
8.4 Propranolol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer


※参考情報

プロプラノロールは、β-アドレナリン受容体遮断薬に分類される薬剤であり、主に心血管系に対する作用が注目されています。この薬は、心拍数の低下や血圧の降低を促進し、さまざまな医療領域で広く使用されています。以下にその定義や特徴、用途などについて詳述いたします。

プロプラノロールの定義としては、選択的ではないβ-アドレナリン受容体遮断薬であり、主に心臓のβ1及び血管のβ2受容体に作用します。そのため、心拍数や心収縮力の低下、血管の拡張が促されます。これにより、心臓の負担を軽減し、心臓病や高血圧の治療に寄与します。

プロプラノロールの特徴の一つは、その速やかな作用です。経口摂取後、比較的短時間で効果が現れ、通常の投与量でも良好な血圧管理が可能です。また、プロプラノロールは脂溶性が高く、血液脳関門を通過しやすいため、神経系に対する影響も少なからず持つことから、これが心の症状の軽減にも寄与するとされています。

この薬は、特に高血圧や狭心症、心筋梗塞後の心保護に使用されることが多いですが、その他にも不安障害や片頭痛の予防、発作性上室性頻拍の治療といった多岐にわたる用途があります。たとえば、パフォーマンス不安を抱えるアスリートや公演者にとって、緊張を和らげる効果が評価されています。

プロプラノロールには、いくつかの種類が存在します。一般的に、薬剤はその用量や製剤の形態によって分類されます。経口錠剤、注射剤、持続放出製剤などがあり、患者の状態やニーズに応じて適切な形態が選ばれます。特に、持続放出製剤は、長時間にわたる効果が期待できるため、患者の服薬アドヒアランスを向上させる役割を果たします。

使われる際には、副作用に注意を払う必要があります。例えば、倦怠感やめまい、低血圧などが報告されており、特に心機能が低下している患者には慎重な投与が求められます。また、喘息などの気道過敏性を有する患者では、気道の収縮を引き起こす可能性があるため、使用が制限されることもあります。

関連技術としては、薬物療法のみならず、生活習慣の改善が推奨されます。適切な食事、運動、ストレス管理を行うことで、プロプラノロールの効果を最大限に引き出し、患者の全体的な健康状態を向上させることができます。

プロプラノロールは、その効果的な作用と多様な用途から、多くの患者にとって有用な治療手段となっています。そのため、医療従事者は適切な知識とスキルを持って投与することが求められます。また、患者自身もその特性を理解し、副作用や禁忌についての情報を持っておくことが重要です。

最後に、プロプラノロールはその有用性から、今後も研究が進むことで新たな適応症やより良い治療法が見つかることが期待されます。心血管系の疾患は、世界中で多くの人々に影響を及ぼしており、その治療においてプロプラノロールは欠かせない薬剤の一つであり続けるでしょう。


★調査レポート[プロプラノロールのグローバル市場2023年：経口、注射] (コード：QYR23MA7537)販売に関する免責事項を必ずご確認ください。
★調査レポート[プロプラノロールのグローバル市場2023年：経口、注射]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆